Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda

Vaccine

Volumn 33, Issue 6, 2015, Pages 796-804

  Lule, Swaib Abubaker ^a   Mawa, Patrice A ^a   Nkurunungi, Gyaviira ^a   Nampijja, Margaret ^a   Kizito, Dennison ^a   Akello, Florence ^b   Muhangi, Lawrence ^a   Elliott, Alison M ^a,c   Webb, Emily L ^c  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b Entebbe Hospital   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Bacille Calmette Guerin; Crude culture filtrate protein; Helminth; HIV; Pregnancy; Tuberculosis

Indexed keywords

ALBENDAZOLE; BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; MYCOBACTERIUM ANTIGEN; PLACEBO; PRAZIQUANTEL; IL10 PROTEIN, HUMAN; IL5 PROTEIN, HUMAN; INTERLEUKIN-13, HUMAN;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; BLOOD SAMPLING; BOOTSTRAPPING; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HELMINTHIASIS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFANT; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; MOTHER; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE DRUG DOSE; TREATMENT RESPONSE; TUBERCULOSIS; UGANDA; URBAN AREA; ADAPTIVE IMMUNITY; BLOOD; COMORBIDITY; HIV INFECTIONS; IMMUNOLOGY; MYCOBACTERIUM BOVIS; PREVALENCE; RURAL POPULATION; URBAN POPULATION; VACCINATION;

ADAPTIVE IMMUNITY; BCG VACCINE; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HELMINTHIASIS; HIV INFECTIONS; HUMANS; INFANT; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-5; LATENT TUBERCULOSIS; MALARIA; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTORS; RURAL POPULATION; UGANDA; URBAN POPULATION; VACCINATION;

EID: 84921614064     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.015     Document Type: Article

References (41)

1. Banfield S., Pascoe E., Thambiran A., Siafarikas A., Burgner D. Factors associated with the performance of a blood-based interferon-gamma release assay in diagnosing tuberculosis. PLoS One 2012, 7:e38556.
2. Kus J., Demkow U., Lewandowska K., Korzeniewska-Kosela M., Rabczenko D., Siemion-Szczesniak I., et al. Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10. Pneumonol Alergol Pol 2011, 79:407-418.
3. Weir R.E., Gorak-Stolinska P., Floyd S., Lalor M.K., Stenson S., Branson K., et al. Persistence of the immune response induced by BCG vaccination. BMC Infect Dis. 2008, 8:9.
4. Soysal A., Millington K.A., Bakir M., Dosanjh D., Aslan Y., Deeks J.J., et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005, 366:1443-1451.
5. Zelner J.L., Murray M.B., Becerra M.C., Galea J., Lecca L., Calderon R., et al. Bacillus Calmette-Guerin and isoniazid preventive therapy protect contacts of patients with tuberculosis. Am J Respir Crit Care Med 2014, 189:853-859.
6. Packe G.E., Innes J.A. Protective effect of BCG vaccination in infant Asians: a case-control study. Arch Dis Child 1988, 63:277-281.
7. Hatherill M. Prospects for elimination of childhood tuberculosis: the role of new vaccines. Arch Dis Child 2011, 96:851-856.
8. Lalor M.K., Ben-Smith A., Gorak-Stolinska P., Weir R.E., Floyd S., Blitz R., et al. Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. J Infect Dis 2009, 199:795-800.
9. Fine P.E. Bacille Calmette-Guerin vaccines: a rough guide. Clin Infect Dis 1995, 20:11-14. (an official publication of the Infectious Diseases Society of America).
10. Wilson M.E., Fineberg H.V., Colditz G.A. Geographic latitude and the efficacy of Bacillus Calmette-Guerin vaccine. Clin Infect Dis 1995, 20:982-991.
11. Thakur A., Pedersen L.E., Jungersen G. Immune markers and correlates of protection for vaccine induced immune responses. Vaccine 2012, 30:4907-4920.
12. Elliott A.M., Hurst T.J., Balyeku M.N., Quigley M.A., Kaleebu P., French N., et al. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study. Int J Tuberc Lung Dis 1999, 3:239-247. (the official journal of the International Union against Tuberculosis and Lung Disease).
13. Anderson E.J., Webb E.L., Mawa P.A., Kizza M., Lyadda N., Nampijja M., et al. The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine 2012, 30:2083-2089.
14. Brosch R., Gordon S.V., Garnier T., Eiglmeier K., Frigui W., Valenti P., et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Nat Acad Sci USA 2007, 104:5596-5601.
15. Brewer T.F., Colditz G.A. Bacille Calmette-Guerin vaccination for the prevention of tuberculosis in health care workers. Clin Infect Dis 1995, 20:136-142. (an official publication of the Infectious Diseases Society of America).
16. Haile M., Kallenius G. Recent developments in tuberculosis vaccines. Curr Opin Infect Dis 2005, 18:211-215.
17. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346:1339-1345.
18. Elliott A.M., Mawa P.A., Webb E.L., Nampijja M., Lyadda N., Bukusuba J., et al. Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine 2010, 29:247-255.
19. Lalor M.K., Floyd S., Gorak-Stolinska P., Ben-Smith A., Weir R.E., Smith S.G., et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis 2011, 204:1075-1085.
20. Fletcher H.A. Correlates of immune protection from tuberculosis. Curr Mol Med 2007, 7:319-325.
21. Rook G.A., Hernandez-Pando R., Zumla A. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination. J Infect Dis 2009, 199:613-618.
22. Higgins D.M., Sanchez-Campillo J., Rosas-Taraco A.G., Lee E.J., Orme I.M., Gonzalez-Juarrero M. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2009, 89:149-157.
23. Rook G.A., Dheda K., Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting. Vaccine 2005, 23:2115-2120.
24. Weiner J., Kaufmann S.H. Recent advances towards tuberculosis control: vaccines and biomarkers. J Intern Med 2014, 275:467-480.
25. Elliott A.M., Kizza M., Quigley M.A., Ndibazza J., Nampijja M., Muhangi L., et al. The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447]. Clin Trials 2007, 4:42-57.
26. Ndibazza J., Mpairwe H., Webb E.L., Mawa P.A., Nampijja M., Muhangi L., et al. Impact of anthelminthic treatment in pregnancy and childhood on immunisations, infections and eczema in childhood: a randomised controlled trial. PLoS One 2012, 7:e50325.
27. Webb E.L., Mawa P.A., Ndibazza J., Kizito D., Namatovu A., Kyosiimire-Lugemwa J., et al. Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial. Lancet 2011, 377:52-62.
28. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972, 14:397-400.
29. Melrose W.D., Turner P.F., Pisters P., Turner B. An improved Knott's concentration test for the detection of microfilariae. Trans R Soc Trop Med Hyg 2000, 94:176.
30. Victora C.G., Huttly S.R., Fuchs S.C., Olinto M.T. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol 1997, 26:224-227.
31. McGuinness D., Bennett S., Riley E. Statistical analysis of highly skewed immune response data. J Immunol Methods 1997, 201:99-114.
32. Rose M.V., Kimaro G., Nissen T.N., Kroidl I., Hoelscher M., Bygbjerg I.C., et al. QuantiFERON(R)-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One 2012, 7:e37851.
33. Wassie L., Aseffa A., Abebe M., Gebeyehu M.Z., Zewdie M., Mihret A., et al. Parasitic infection may be associated with discordant responses to QuantiFERON and tuberculin skin test in apparently healthy children and adolescents in a tuberculosis endemic setting, Ethiopia. BMC Infect Dis 2013, 13:265.
34. Kidzeru E.B., Hesseling A.C., Passmore J.A., Myer L., Gamieldien H., Tchakoute C.T., et al. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS 2014, 28:1421-1430.
35. Mazzola T.N., da Silva M.T., Abramczuk B.M., Moreno Y.M., Lima S.C., Zorzeto T.Q., et al. Impaired Bacillus Calmette-Guerin cellular immune response in HIV-exposed, uninfected infants. AIDS 2011, 25:2079-2087.
36. Elliott A.M., Namujju P.B., Mawa P.A., Quigley M.A., Nampijja M., Nkurunziza P.M., et al. A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guerin (BCG) immunisation [ISRCTN32849447]. BMC Infect Dis 2005, 5:115.
37. Davids V., Hanekom W.A., Mansoor N., Gamieldien H., Gelderbloem S.J., Hawkridge A., et al. The effect of Bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis 2006, 193:531-536.
38. Ritz N., Dutta B., Donath S., Casalaz D., Connell T.G., Tebruegge M., et al. The influence of Bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Am J Respir Crit Care Med 2012, 185:213-222.
39. Behr M.A. BCG-different strains, different vaccines. Lancet Infect Dis 2002, 2:86-92.
40. Mangtani P., Abubakar I., Ariti C., Beynon R., Pimpin L., Fine P.E., et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014, 58:470-480. (an official publication of the Infectious Diseases Society of America).
41. Bennett A.R., Gorak-Stolinska P., Ben-Smith A., Floyd S., de Lara C.M., Weir R.E., et al. The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 months. Vaccine 2006, 24:2617-2626.